Daniel J. Powell

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors”.

Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors

Journal of Clinical Investigation(2024)10.1172/jci175790

N/A

0.794DataRank · unranked

28 citations

Rebecca B. Nadler, Mark H. O’Hara, Kelsey Stanton, Chong Xu, Robert Saporito +14 more

Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting

Nature Communications(2021)10.1038/s41467-021-24562-2

N/A

0DataRank · unranked

112 citations

Tatiana Blanchard, Joseph Cesare, Michael Ford, Lee P. Richman, Chong Xu +14 more

Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs

European Journal of Immunology(2021)10.1002/eji.202149329

N/A

0DataRank · unranked

45 citations

Dalia K. Omran, Jessica Chacon, Daniel J. Powell, Monika A. Eiva

Epigenetic state determines inflammatory sensing in neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.27.428523

N/A

0DataRank · unranked

6 citations

Liron D. Grossmann, May M. Dong, Jessica L. Dessau, Patricia Brafford, Darya Volgina +8 more

Systematic analysis of CD39, CD103, CD137 and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.29.437255

N/A

0DataRank · unranked

2 citations

Dalia K. Omran, Jessica Chacon, Daniel J. Powell, Monika A. Eiva

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

Communications Biology(2022)10.1038/s42003-022-04209-8

N/A

0DataRank · unranked

24 citations

Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel +18 more

TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones

Blood Advances(2022)10.1182/bloodadvances.2022008798

N/A

0DataRank · unranked

10 citations

Mathilde Poussin, Alba Rodríguez-García, Joshua T. Eggold, Nicholas G. Minutolo, Jie Wang +4 more

A CD45RO+ stem cell memory T cell population intermediate to canonical stem cell memory and central memory T cells in human cancer.

Research Square(2022)10.21203/rs.3.rs-1296773/v1

N/A

0DataRank · unranked

1 citations

Monika A. Eiva, Erica C. Brown, Veethika Pandey, Alexander Benton, Stacy J. Thomas +4 more

885 Enhancing immune checkpoint inhibitor efficacy with anti-angiogenics in ovarian cancer

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0885

N/A

0DataRank · unranked

0 citations

S. P. Medvedev, Veethika Pandey, Dalia K. Omran, Matthew Anderson, Lauren E. Schwartz +3 more

A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1079

N/A

0DataRank · unranked

34 citations

Margaret Whicker, Gareth Davies, Sushil Kumar, Krista Kinneer, Haineng Xu +13 more

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)

Journal of Translational Medicine(2023)10.1186/s12967-023-04329-7

N/A

0DataRank · unranked

11 citations

Antonio Avallone, Carlo Bifulco, Sergio Bracarda, Joshua Brody, Leisha A. Emens +19 more

CD5 deletion enhances the antitumor activity of adoptive T cell therapies

Science Immunology(2024)10.1126/sciimmunol.adn6509

N/A

0DataRank · unranked

48 citations

Guido Ghilardi, Yunlin Zhang, Yi‐Hao Chiang, Wei Xie, Puneeth Guruprasad +46 more

Adoptive T cell therapy for ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.04.001

N/A

0DataRank · unranked

27 citations

Chibuike Ihewulezi, Daniel J. Powell, Sarah B. Gitto

CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.029

N/A

0DataRank · unranked

8 citations

Monika A. Eiva, Fang Liu, Dalia K. Omran, Stefan Gysler, Erica Brown +7 more

A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitope

Mobile DNA(2024)10.1186/s13100-024-00333-w

N/A

0DataRank · unranked

2 citations

Lauren Shaw, Loretta Wang, Abigail V. Lee, James Castro Argueta, Daniel J. Powell +8 more

Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in Cancer

Research Square(2024)10.21203/rs.3.rs-4432372/v1

N/A

0DataRank · unranked

0 citations

Lauren Shaw, Loretta Wang, Daniel J. Powell, Mario Ostrowski, R. Brad Jones +5 more

Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy

Cancer Cell(2025)10.1016/j.ccell.2025.05.006

N/A

0DataRank · unranked

28 citations

Jia‐Geng Liu, Mathilde Poussin, Andrea Lang Goldgewicht, Madhara Udawela, Adham S. Bear +7 more

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

Cancer Cell(2021)10.1016/j.ccell.2021.10.008

N/A

0DataRank · unranked

197 citations

Riccardo Turrini, Aspram Minasyan, David Barras, Isaac Crespo, Alizée J Grimm +31 more

NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas

Cell Reports(2025)10.1016/j.celrep.2025.116099

N/A

0DataRank · unranked

5 citations

Ammar S. Naqvi, Makenna Higgins, Jia‐Geng Liu, Kyra Harvey, Julien Jarroux +25 more